DAILYZ HEALTH NEWS

Pennsylvania reports its first measles deaths in 35 years, with two unvaccinated individuals dying amid a 393-case outbreak in 29 counties.

Health

August 27, 2026 Evan Vega

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

The FDA approved LISRAYA (brepocitinib), the first oral TYK2/JAK1 inhibitor for treating adult dermatomyositis, on August 27, 2026.

Health

August 22, 2026 Evan Vega

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

The FDA upgraded the recall of 1.6 million Midwest Poultry eggs to Class I due to a multistate Salmonella Enteritidis outbreak in 2026.

Health

August 22, 2026 Evan Vega

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

Atrium Health partners with Morehouse School of Medicine, investing over $700 million to build a new hospital and expand healthcare in South and West Atlanta.

Health

August 22, 2026 Evan Vega

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

OHSU study finds psilocybin safe and effective for treating mood disorders in over 2,300 users in Oregon’s real-world settings.

Health

August 20, 2026 Evan Vega

Rare disease drug recalled in Ireland after deaths in Japan

Irish authorities recalled the rare disease drug Tavneos after reports of about 20 deaths linked to liver dysfunction in Japan since 2022.

Health

August 20, 2026 Evan Vega

FDA approves new imaging agent for Alzheimer’s disease detection

The FDA approved Tauklarify, a tau PET imaging agent, for detecting tau pathology in adults evaluated for Alzheimer’s disease.

Health

August 20, 2026 Evan Vega

FDA approves Glenmark’s generic fluticasone propionate nasal spray

The FDA approved Glenmark’s generic Fluticasone Propionate Nasal Spray, equivalent to Flonase, for treating allergic rhinitis symptoms in the U.S.

Health

August 4, 2026 Evan Vega

FDA expands Pluvicto approval to earlier-stage metastatic prostate cancer, nearly doubling eligible patients

The FDA approved Pluvicto with androgen receptor inhibitors for earlier-stage PSMA-positive metastatic hormone-sensitive prostate cancer, expanding patient eligibility.

Health

August 4, 2026 Evan Vega

Prescription blood thinner recalled nationwide amid FDA warning

Alkem Laboratories and Major Pharmaceuticals recalled 299,520 dabigatran etexilate capsules nationwide due to FDA quality concerns.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

Pennsylvania records its first measles deaths in 35 years

FDA approves brepocitinib, the first oral drug for dermatomyositis in adults

FDA Elevates Massive Egg Recall to Highest-Risk Salmonella Warning

Atrium Health Commits More Than $700 Million in Partnership with Morehouse School of Medicine

OHSU-Led Study Finds Psilocybin Safe and Effective for Mood Disorders in 2,300 Real-World Users

Rare disease drug recalled in Ireland after deaths in Japan

FDA approves new imaging agent for Alzheimer’s disease detection

FDA approves Glenmark’s generic fluticasone propionate nasal spray

FDA expands Pluvicto approval to earlier-stage metastatic prostate cancer, nearly doubling eligible patients

Prescription blood thinner recalled nationwide amid FDA warning